Biocon Biologics Switzerland AG

Pharmaceuticals · Zürich, Zurich

Biocon Biologics Switzerland AG is a Swiss pharmaceuticals company based in Zürich, Canton of Zurich, listed in the Swiss commercial register since 2023 (UID CHE-161.686.450).

Legal nameBiocon Biologics Switzerland AG
AddressWiesenstrasse, Zürich
UID / VATCHE-161.686.450
Legal form · StatusAG · Active · 2023

Board members & signatories

  • Shreehas Tambe — Präsident des Verwaltungsrates
  • Kedar Upadhye — Mitglied des Verwaltungsrates
  • Marie-Théodora Vandewiele

Registered purpose

Die Gesellschaft bezweckt die Vermarktung, Vertrieb und Verkauf, von Phamazeutika, Biopharmazeutika und biologischen Produkten. Die Gesellschaft kann Grundstücke im In- und Ausland erwerben, halten und veräussern und alle finanziellen, kommerziellen und anderen Tätigkeiten ausüben, welche mit dem Zweck der Gesellschaft direkt oder indirekt im Zusammenhang stehen. Die Gesellschaft ist Teil einer Gr…

🔒 Website🔒 Employees🔒 Revenue estimate

Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026

What Biocon Biologics Switzerland does

OFFERING

Biocon Biologics offers a broad pipeline of 20 biosimilar molecules, including ten commercialized products such as Trastuzumab, Adalimumab, and Insulin Glargine. The company focuses on providing affordable access to life-saving medicines through its global biosimilars portfolio, which spans insulins, monoclonal antibodies, and conjugated recombinant proteins.

Unlock the full analysis →

Similar companies

Find every pharmaceuticals company in Switzerland

Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.

family-owned pharmaceuticals companies with 50+ employees…Search →

Full profiles from CHF 49/month · Cancel anytime